{"DataElement":{"publicId":"3446951","version":"1","preferredName":"Leiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 Clinical Regional Lymph Node N Stage","preferredDefinition":"Extent of the regional lymph node involvement for the leiomyosarcoma and endometrial stromal sarcoma based on evidence obtained from clinical assessment parameters determined prior to treatment.","longName":"3444902v1.0:3446146v1.0","context":"NCI Standards","contextVersion":"1","DataElementConcept":{"publicId":"3444902","version":"1","preferredName":"Leiomyosarcoma and Endometrial Stromal Sarcoma Clinical N Stage","preferredDefinition":"A malignant mesenchymal tumor arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma. -- 2004__Relating to the examination and treatment of patients dependent on direct observation. The term may also refer to the institution (clinic) providing this activity._One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","longName":"3444898v1.0:2428496v1.0","context":"NCIP","contextVersion":"1","ObjectClass":{"publicId":"3444898","version":"1","preferredName":"Uterine Corpus Sarcoma","preferredDefinition":"A malignant mesenchymal tumor arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma. -- 2004","longName":"C6339","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Uterine Corpus Sarcoma","conceptCode":"C6339","definition":"A malignant mesenchymal neoplasm arising from the wall of the uterine corpus (uterine body).  The most representative examples are leiomyosarcoma and endometrial stromal sarcoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFC61B5-2A74-B731-E040-BB89AD4344A0","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"ONEDATA","dateModified":"2012-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2428496","version":"1","preferredName":"Clinical N Stage","preferredDefinition":"Having to do with the examination and treatment of patients.:One criteria of the TMN staging system. N refers to the extent of lymph node involvement.","longName":"C25398:C25580","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Clinical","conceptCode":"C25398","definition":"Relating to the examination and treatment of patients dependent on direct observation.  The term may also refer to the institution (clinic) providing this activity.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"053C2A34-0888-693F-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-11-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2005-11-11","modifiedBy":"ONEDATA","dateModified":"2005-11-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFC61B5-2AA6-B731-E040-BB89AD4344A0","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"3446146","version":"1","preferredName":"Leiomyosarcoma and Endometrial Stromal Sarcoma American Joint Committee on Cancer (AJCC) Edition 7 N Stage","preferredDefinition":"A finding about one or more characteristics of leiomyosarcoma and endometrial stromal sarcoma, following the rules of the TNM AJCC v7 classification system._A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications._One criteria of the TNM staging system. N refers to the extent of lymph node involvement._The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"3446146v1.0","context":"NCIP","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":"2","maxLength":"2","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"N0","valueDescription":"Leiomyosarcoma and Endometrial Stromal Sarcoma pN0 TNM Finding v7","ValueMeaning":{"publicId":"3446148","version":"1","preferredName":"Leiomyosarcoma and Endometrial Stromal Sarcoma pN0 TNM Finding v7","longName":"3446148","preferredDefinition":"No regional lymph node metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma and Endometrial Stromal Sarcoma pN0 TNM Finding v7","conceptCode":"C89598","definition":"No regional lymph node metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFD3837-B514-9AD8-E040-BB89AD431C21","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEFD3837-B52D-9AD8-E040-BB89AD431C21","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"ONEDATA","dateModified":"2012-05-01","deletedIndicator":"No"},{"value":"N1","valueDescription":"Leiomyosarcoma and Endometrial Stromal Sarcoma pN1 TNM Finding v7","ValueMeaning":{"publicId":"3446150","version":"1","preferredName":"Leiomyosarcoma and Endometrial Stromal Sarcoma pN1 TNM Finding v7","longName":"3446150","preferredDefinition":"Regional lymph node metastasis. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma and Endometrial Stromal Sarcoma pN1 TNM Finding v7","conceptCode":"C89599","definition":"Regional lymph node metastasis. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFD3837-B53A-9AD8-E040-BB89AD431C21","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEFD3837-B553-9AD8-E040-BB89AD431C21","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"ONEDATA","dateModified":"2012-05-01","deletedIndicator":"No"},{"value":"NX","valueDescription":"Leiomyosarcoma and Endometrial Stromal Sarcoma pNX TNM Finding v7","ValueMeaning":{"publicId":"3446152","version":"1","preferredName":"Leiomyosarcoma and Endometrial Stromal Sarcoma pNX TNM Finding v7","longName":"3446152","preferredDefinition":"Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma and Endometrial Stromal Sarcoma pNX TNM Finding v7","conceptCode":"C89597","definition":"Regional lymph nodes cannot be assessed. (from AJCC 7th Ed.)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFD3837-B560-9AD8-E040-BB89AD431C21","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"BEFD3837-B579-9AD8-E040-BB89AD431C21","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"ONEDATA","dateModified":"2012-05-01","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"3446145","version":"1","preferredName":"Leiomyosarcoma and Endometrial Stromal Sarcoma TNM Finding v7 American Joint Committee on Cancer N Stage Stage","preferredDefinition":"A finding about one or more characteristics of leiomyosarcoma and endometrial stromal sarcoma, following the rules of the TNM AJCC v7 classification system.:A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.:One criteria of the TNM staging system. N refers to the extent of lymph node involvement.:The extent of a cancer within the body, especially whether the disease has spread from the original site to other parts of the body.","longName":"C89581:C39315:C25580:C16899","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Leiomyosarcoma and Endometrial Stromal Sarcoma TNM Finding v7","conceptCode":"C89581","definition":"A finding about one or more characteristics of leiomyosarcoma and endometrial stromal sarcoma, following the rules of the TNM AJCC v7 classification system.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"American Joint Committee on Cancer","conceptCode":"C39315","definition":"A group formed for the purpose of developing a system of clinical staging for cancer that is acceptable to the American medical profession and is compatible with other accepted classifications.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"N Category","conceptCode":"C25580","definition":"One criteria of the TNM staging system. N refers to the extent of lymph node involvement.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm Stage","conceptCode":"C16899","definition":"The extent of a cancer in the body.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFD3837-B4E8-9AD8-E040-BB89AD431C21","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"ONEDATA","dateModified":"2012-05-01","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Application","id":"BEFD3837-B4F9-9AD8-E040-BB89AD431C21","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"COOPERM","dateModified":"2012-05-07","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2192345","version":"1","longName":"Data Standards","context":"NCIP","ClassificationSchemeItems":[{"publicId":"2859963","version":"1","longName":"Standard CRFs","context":"NCIP"},{"publicId":"3434437","version":"1","longName":"Staging/Extent of Disease (by Disease)","context":"NCIP"},{"publicId":"3444895","version":"1","longName":"Corpus Uteri Sarcoma","context":"NCIP"}]},{"publicId":"3461150","version":"1","longName":"Staging","context":"NCIP","ClassificationSchemeItems":[{"publicId":"3461151","version":"1","longName":"AJCC Edition 7","context":"NCIP"}]},{"publicId":"5574838","version":"1","longName":"Staging/Extent of Disease","context":"NCI Standards","ClassificationSchemeItems":[{"publicId":"10000596","version":"1","longName":"AJCC Edition 7","context":"NCI Standards"},{"publicId":"5777522","version":"1","longName":"LMS Endo SS","context":"NCI Standards"}]}],"AlternateNames":[{"name":"LCC","type":"USED_BY","context":"LCC"},{"name":"AECC","type":"USED_BY","context":"AECC"},{"name":"CITN","type":"USED_BY","context":"CITN"},{"name":"PBTC","type":"USED_BY","context":"PBTC"},{"name":"OHSU Knight","type":"USED_BY","context":"OHSU Knight"}],"ReferenceDocuments":[{"name":"Clinical N Stage","type":"Preferred Question Text","description":"Clinical N Stage","url":null,"context":"NCI Standards"}],"origin":"AJCC Based:Staging Criteria Based on American Joint Committee on Cancer System","workflowStatus":"RELEASED","registrationStatus":"Preferred Standard","id":"BEFF3D8E-2797-4741-E040-BB89AD4311DA","latestVersionIndicator":"Yes","beginDate":"2012-05-01","endDate":null,"createdBy":"COOPERM","dateCreated":"2012-05-01","modifiedBy":"HARTLEYG","dateModified":"2021-06-17","changeDescription":"Created for CRF standard harmonization. Released per final community approval. mc 5/7/12","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}